These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 738210)
1. Abnormal growth hormone response in obesity with normal carbohydrate tolerance and normal thyroid function. Ratzmann KP; Gottschling HD Endokrinologie; 1978 May; 72(2):149-54. PubMed ID: 738210 [TBL] [Abstract][Full Text] [Related]
2. [Effect of insulin on stimulated lipolysis in obesity with normal carbohydrate tolerance and unimpaired thyroid function]. Ratzmann KP Endokrinologie; 1977 Oct; 70(2):199-211. PubMed ID: 590207 [TBL] [Abstract][Full Text] [Related]
3. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. Williams T; Berelowitz M; Joffe SN; Thorner MO; Rivier J; Vale W; Frohman LA N Engl J Med; 1984 Nov; 311(22):1403-7. PubMed ID: 6436706 [TBL] [Abstract][Full Text] [Related]
4. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity. Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002 [TBL] [Abstract][Full Text] [Related]
5. The influence of thyroid function on the diabetogenic action of triamcinolone in man. Glucose, insulin and growth hormone patterns after on oral glucose load. Zamrazil V; Nedvĭdková J; Felt V; Nĕmec J; Havelka J Horm Metab Res; 1976 Jul; 8(4):282-6. PubMed ID: 955557 [TBL] [Abstract][Full Text] [Related]
6. The influence of plasma triglycerides on human growth hormone response to arginine and insulin: a study in hyperlipemics and normal subjects. Muggeo M; Tiengo A; Fedele D; Crepaldi G Horm Metab Res; 1975 Sep; 7(5):367-74. PubMed ID: 1183914 [TBL] [Abstract][Full Text] [Related]
7. [Lipid mobilization in obesity without carbohydrate intolerance. 2. Caffeine-stimulated lipolysis]. Ratzmann KP; Riemer D; Männchen E; Paul I Endokrinologie; 1976; 68(3):319-26. PubMed ID: 1009910 [TBL] [Abstract][Full Text] [Related]
8. Plasma growth hormone response to oral clonidine as compared to insulin hypoglycemia in obese children and adolescents. Topper E; Gil-Ad I; Bauman B; Josefsberg Z; Laron Z Horm Metab Res; 1984 Dec; 16 Suppl 1():127-30. PubMed ID: 6398251 [TBL] [Abstract][Full Text] [Related]
9. [Study on the effect of insulin on carbohydrate and lipid metabolism in obese subjects with normal glucose tolerance]. Ratzmann VK; Wittig M; Krause G; Männchen E Z Gesamte Inn Med; 1975 Aug; 30(15):489-94. PubMed ID: 1189493 [TBL] [Abstract][Full Text] [Related]
10. Changes of early insulin responses to glucose in obese subjects with normal and impaired carbohydrate tolerance. Ratzmann KP; Schulz B; Witt S; Heinke P; Ziegler M Endokrinologie; 1981 Oct; 78(1):89-98. PubMed ID: 7032897 [TBL] [Abstract][Full Text] [Related]
11. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance]. Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458 [TBL] [Abstract][Full Text] [Related]
12. Effect of lipids on growth hormone secretion in humans. Blackard WG; Hull EW; Lopez A J Clin Invest; 1971 Jul; 50(7):1439-43. PubMed ID: 5090059 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484 [TBL] [Abstract][Full Text] [Related]
14. [Circulating somatostatin concentrations in childhood. Studies in normal weight and obese children and patients with growth hormone deficiency]. Rosskamp R; Becker M; Zallet M Monatsschr Kinderheilkd; 1986 Dec; 134(12):849-53. PubMed ID: 2881199 [TBL] [Abstract][Full Text] [Related]
15. Abnormalities in the regulation of growth hormone in chronic renal failure. Ramirez G; O'Neill WM; Bloomer HA; Jubiz W Arch Intern Med; 1978 Feb; 138(2):267-71. PubMed ID: 626554 [TBL] [Abstract][Full Text] [Related]
16. Decreased growth hormone levels in the catabolic phase of severe injury. Jeevanandam M; Ramias L; Shamos RF; Schiller WR Surgery; 1992 May; 111(5):495-502. PubMed ID: 1598669 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretion in women with hypothalamic, maternal and simple obesity. Part II. Komorowski JM Endokrinologie; 1977 Oct; 70(2):192-8. PubMed ID: 590206 [TBL] [Abstract][Full Text] [Related]
18. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. Rosenfeld RG; Wilson DM; Dollar LA; Bennett A; Hintz RL J Clin Endocrinol Metab; 1982 May; 54(5):1033-8. PubMed ID: 7037819 [TBL] [Abstract][Full Text] [Related]
19. Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects. Laurian L; Oberman Z; Ayalon D; Cordova T; Herzberg M; Horer E; Harell A Isr J Med Sci; 1975 May; 11(5):482-7. PubMed ID: 1158662 [TBL] [Abstract][Full Text] [Related]
20. Serum growth hormone and somatomedin-C in patients with bilharzial hepatic fibrosis and post hepatitic cirrhosis. el-Hawy AM; el-Nasr MS; Mahgob MA; Mostafa N J Egypt Soc Parasitol; 1991 Apr; 21(1):135-44. PubMed ID: 2033287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]